After fulfilment of the local transfer requirements and approval of all relevant authorities, Swiss specialty chemical company Clariant completed the sale of its Pharmaceutical Fine Chemicals unit to TowerBrook Capital Partners, L.P. on June 30, for CHF110 million ($89.7 million).

Clariant, which is represented on five continents with over 100 group companies, employs approximately 23,000 people. Its businesses are organised into five divisions: Textile, Leather & Paper Chemicals, Pigments & Additives, Functional Chemicals, Life Science Chemicals and Masterbatches.